Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Diurnal’s Chronocort fails in phase 3 congenital adrenal hyperplasia trial
Image: Diurnal’s Chronocort failed to meet the primary objective of a phase 3 congenital adrenal hyperplasia trial. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.
Image: Diurnal’s Chronocort failed to meet the primary objective of a phase 3 congenital adrenal hyperplasia trial. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.